Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JAK2-IN-6, a polysubstituted aminothiazole derivative, is a potent and selective inhibitor of JAK2 (ic50 at 22.86 μg/mL). Jak2-in-6 inhibits the activity of JAK2 enzymes by interfering with Jak2-related signaling pathways, thereby producing therapeutic effects on the specific disease IN which JAK2 is dysregulated, and does not show activity on JAK1 and JAK3. JAK2 is a protein involved in signaling pathways that regulate cell growth and division. Abnormal activation of JAK2 has been linked to a variety of diseases, including some types of cancer and inflammatory diseases. JAK2-IN-6 has antiproliferative activity against cancer cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 39.00 | |
5 mg | In stock | $ 89.00 | |
10 mg | In stock | $ 128.00 | |
25 mg | In stock | $ 219.00 | |
50 mg | In stock | $ 326.00 | |
100 mg | In stock | $ 486.00 | |
500 mg | In stock | $ 1,060.00 |
Description | JAK2-IN-6, a polysubstituted aminothiazole derivative, is a potent and selective inhibitor of JAK2 (ic50 at 22.86 μg/mL). Jak2-in-6 inhibits the activity of JAK2 enzymes by interfering with Jak2-related signaling pathways, thereby producing therapeutic effects on the specific disease IN which JAK2 is dysregulated, and does not show activity on JAK1 and JAK3. JAK2 is a protein involved in signaling pathways that regulate cell growth and division. Abnormal activation of JAK2 has been linked to a variety of diseases, including some types of cancer and inflammatory diseases. JAK2-IN-6 has antiproliferative activity against cancer cells. |
Targets&IC50 | JAK2:22.86 μg/mL |
In vitro | The treatment of JAK2-IN-6 (Compound B2; 6.3-50 μg/mL; 48 hours) demonstrates significant antiproliferative activity against PC-9, H1975, and PANC-1 cell lines. The IC50 values for PC-9, H1975, and PANC-1 cell lines are 18.1 μg/mL, 58.3 μg/mL, and 40.6 μg/mL, respectively [1]. |
Synonyms | JAK2-IN-6 |
Molecular Weight | 335.83 |
Formula | C14H10ClN3OS2 |
CAS No. | 353512-04-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 54.0 mg/mL (160.8 mM), when pH is adjusted to 5 with HCl. Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JAK2-IN-6 353512-04-6 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells JAK JAK-2-IN-6 JAK2IN6 JAK2 IN 6 inhibitor inhibit